M-line is the narrow transverse band located in the center of the sarcomeric A-band that is mainly responsible for the stabilization of myosin thick filaments. A 27-year-old male patient with a positive medical history for ankylosing spondylitis presented with one month of proximal upper limb muscle weakness associated with pain on both acromioclavicular joints. A biopsy of deltoid muscle documented the disappearance of M-line, the misalignment of myofilaments, and the loss of the distinction between the A and I bands. Complete resolution of muscle weakness occurred after one year of treatment with antiTNFa agent Etanercept. Because of the acute onset of symptoms and the recovery after immunosuppressive treatment we hypothesized that an immune-mediated mechanism was responsible for the muscle disorder. The serum IgG-mediated autoreactivity to skeletal muscle antigens resolved by bidimensional electrophoresis was assessed in the described patient and compared with that of control subjects. The comparative analysis of the immunoreactive spots revealed that ATP synthase subunit a is specifically recognized by patient's serum, suggesting that the protein might represent a putative antigenic target in the disease. This study reports an acute reversible myopathy pathologically characterized by M-line involvement and associated with serological antibodies to the subunit a of ATP synthase.
INTRODUCTION
M-line is the sarcomeric structure located in the center of the A-band that anchors thick filaments and that is responsible for their regular packaging, supporting the structural organization and contractile functions of the myofiber. Myosin rods localize at the M-line and are connected to each other through M-bridges that are required to maintain thick filament alignment and distribute mechanical stress across the sarcomere during active contraction. In addition to the rod region of myosin, several proteins have been localized to the M-band, which has been defined as a biochemically highly specific compartment (1) .
In the present study, we report a male patient with ankylosing spondylitis who developed acute reversible proximal upper limb muscle weakness and showed on muscle biopsy dissolution of M-line with misalignment of myofilaments. An autoimmune basis for the myopathy was suspected and, by using a proteomic approach, ATP synthase subunit a was identified as specifically recognized by the patient's serum.
MATERIALS AND METHODS

Case Report
A 27-year-old man came to our attention because of acute shoulder muscle weakness with pain on both acromioclavicular articulation for one month. The patient was unable to rise and abduct his arms, first the left shoulder and then the right one a few days later. His past medical history disclosed HLA-B27-positive ankylosing spondylitis. Laboratory investigations showed increased levels of erythrocyte sedimentation rate (39; normal <20) whereas C-reactive protein, creatine kinase, and thyroid function were in the normal range; antinuclear antibodies were negative. Ultrasound examination of shoulders was normal and shoulder magnetic resonance imaging (MRI) documented mild arthrosis. Cervical and dorsal spine MRI, skeleton and chest X-ray, and electrocardiogram did not show any abnormality. Cerebrospinal fluid (CSF) examination was normal and CSF oligoclonal bands were absent. Whole-body scintigraphy documented hypercaptation in bilateral knee and tarsus, left metatarsophalangeal joint of the first toe, right acromioclavicular, and left sacroiliac joints. A combination treatment of high-dose steroid (500 mg/day) for 5 days and Sulfasalazine was started for the suspicion of disease recurrence. After 15 days of treatment, proximal muscle weakness remained unchanged. On neurological examination the patient was able to abduct arms up to 30
; deep tendon reflexes, sensation, and cranial nerves were normal. Nerve conduction studies were normal while electromyography recorded a myopathic pattern at the deltoid, supraspinatus, trapezius, and brachial triceps muscle. A biopsy of the left deltoid was performed and the histological diagnosis of myopathy with focal loss of myofilaments was initially made. Four months later Sulfasalazine was withdrawn and, due to the lack of efficacy, the patient was switched to antitumor necrosis factor (TNF)-a therapy (Etanercept 25 mg subcutaneously twice weekly). At 2-year follow-up, the patient reported normal motility of the right arm within 10 months and of left arm within 14 months from muscle biopsy; he had no other episodes of muscle weakness.
Histology, Histochemistry, and Immunocytochemistry
Open biopsy from left deltoid muscle was obtained after informed consent. Serial 10-mm-thick cryosections were stained with standard histological and histochemical methods including hematoxylin and eosin, modified Gomori trichrome, adenosine triphosphatase (ATPase) at pH 4.3, 4.6, 10.4), succinate dehydrogenase, cytochrome c oxidase, nicotinamide adenine dinucleotide-tetrazolium reductase (NADH-TR), periodic acid-Schiff, Sudan black, and acid phosphatase (2) . Immunohistochemistry was performed on 8-mm-thick transverse muscle sections with antibodies to major histocompatibility complex (MHC) class I and to membrane attack complex as previously described (2).
Electron Microscopy
A small fragment of muscle tissue was fixed in 2.5% glutaraldehyde in phosphate buffer, postfixed in 2% osmium tetroxide, dehydrated and embedded in Spurr resin. Semithin sections were stained with toluidine blue and periodic acidSchiff. Ultrathin sections were stained with uranyl acetate and lead citrate and examined in a Zeiss EM 109 electron microscope (3).
Patient Sera
Sera were obtained for diagnostic purposes and after written informed consent. Controls were sera from 13 healthy donors and 80 subjects affected with polymyositis (n ¼ 28), dermatomyositis (n ¼ 30), overlap syndrome (n ¼ 11), immune-mediated necrotizing myopathy (n ¼ 3), and myofibrillar myopathy (n ¼ 8).
2-Dimensional (2D) Gel Electrophoresis and Immunoblot Analysis
Twenty-micrometer-thick frozen muscle sections were homogenized in 2D lysis buffer (7 M urea, 2 M thiourea, 0.4% CHAPS, 0.1% DTT, 0.5% TritonX-100) (2) . Protease inhibitors cocktail was added to the solubilizing solution immediately before the experiment. Protein concentration was determined with the Bradford method. Protein load was 60 lg for analytical gels, 120 lg for transfer gels, and 750 lg for preparative gels. The isoelectric focusing (first dimension) was carried out on nonlinear wide-range immobilized pH gradients (pH 3-10; 18-cm-long IPG strips) and the second dimension was performed on 6%-18% T polyacrylamide linear gradient gels as previously reported (2) . Analytical gels were stained with ammoniacal silver nitrate as previously described (2) . Gels to transfer were blotted on 0.2-mm nitrocellulose membranes and stained with Ponceau S red to get references of protein migration on acetate sheets and facilitate the computeraided matching of silver stained gel (2) . The membranes were prehybridized with TBS in 10% BSA, 0.1% Tween 20 and incubated overnight with patients' sera (diluted 1:10 000) in TBS with 1% BSA and 0.1% Tween 20 and then with goat antihuman IgG horseradish peroxidase-conjugated. Protein spots were detected with the ECL Advance Western Blotting Detection Kit (2). The analytical gel and the 2D immunoblot images were matched and analyzed with the Image Master 2D Platinum v6.0 software (2). For spot validation, membranes were prehybridized with 10% milk in TBS, 0.1%Tween-20, and incubated overnight at 4 C with antiATP synthase subunit a antibody (BD Transduction Laboratories, Franklin Lakes, NJ 1:5000) and with peroxidase-conjugated antimouse IgG for 1 hour at room temperature (RT) (2) . The detection of the immunoblot signal was carried with the ECL Advance Western Blotting Detection Kit (2). The analytical gel, the images of 2D immunoblot obtained with patient's serum and with the antiATP synthase subunit a antibody were matched and analyzed with the Image Master 2D Platinum v6.0 software.
In-Gel Digestion and Protein Identification by Mass Spectrometry
A preparative 2D gels was stained with a MScompatible silver staining procedure and the spots of interest were manually excised, destained and dehydrated as previously described (4). Protein identification was performed after in-gel trypsin digestion, as previously described (4). Briefly, peptides from each sample were separated by RP nano-HPLC-Chip technology (Agilent Technologies, Palo Alto, CA) online-coupled with a 3D ion trap mass spectrometer (model Esquire 6000, Bruker Daltonics, Bremen, Germany). Database searches were conducted using the MS/MS ion search of Mascot against human entries of the nonredundant NCBIprot.
IgG Purification and Biotinylation
IgG antibodies were purified from sera on protein G Sepharose columns according to the manufacturer's instructions. After elution the purified immunoglobulins were dialyzed against NaHCO 3 0.1 M pH ¼ 8.0 and biotinylated at RT for 5 hours using the (þ)-Biotin N-hydroxysuccinimide ester (Sigma-Aldrich, St. Louis, MO). After an extensive dialysis against PBS pH ¼ 7.4 to eliminate free biotin, the biotinylated antibodies were quantified and the biotinylation was checked by Dot Blot assay using a biotinylated commercial antibody as positive control. 
Immunofluorescence
Immunofluorescence for ATP synthase subunit a (BD transduction Laboratories, 1:500) was performed on 8-mmthick transverse muscle sections from 3 healthy controls, as previously described (2) . Nuclei were counterstained with Hoechst 33258.
The immunoreactivity of biotinylated IgG extracted from serum of patient and of 3 control subjects was tested on 8-mm-thick transverse muscle sections from a control subject.
RESULTS
Pathologic Features
Muscle biopsy documented many atrophic fibers intermingled with normal-sized ones; atrophic fibers belonged prominently to type 2B (Fig. 1A, B) . Neither necrotic nor regenerating muscle fibers were observed and a pericellular inflammatory infiltrate was present (Fig. 1A) . Focal reduction of ATPase reactivity was observed in some fibers (Fig. 1B) . Oxidative enzyme stains occasionally showed focal loss of reactivity (Fig. 1C) while the amount of lipid droplets and glycogen was normal. No abnormal staining for MHC class I and MAC was found.
At ultrastructural level the main findings were the disappearance of the M-line and the misalignment of thick filaments sliding towards Z-lines, with loss of the distinction between the A and I bands in one or more contiguous sarcomeres, or also in half-sarcomere (Fig. 1D) . Z-lines limiting the abnormal sarcomeres were well preserved with a zig-zag course and streaming Z-lines was only occasionally observed. In some areas, Z bands and myofibrils were replaced by stripes of dense material whereas the contiguous sarcomeres retained their normal structure (Fig. 1E) . The length of abnormal sarcomeres was slightly increased compared with the normal one. 
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Acute Sarcomeric M-Line Disease Mitochondria had normal morphology and there was not increase of lipid droplets and glycogen particles.
Identification of Protein Specifically Recognized by Patient's Serum IgG
Immunoblot analysis with patient's serum IgG as well as with serum IgG of healthy and disease subjects on skeletal muscle proteins resolved by 2D-PAGE ( Fig. 2A) showed a wide range of reactivity to skeletal muscle antigens (Fig. 2B) . After matching of the 2D immunoblot maps, 2 spots resulted to be specifically recognized by patient's serum (Fig. 2B) . Mass spectrometry identified the spots as ATP synthase subunit a (Spot ID: 1166; NCBI acc#: NP_004037.1; Mascot score: 97; N of identified peptides: 5; Sequence coverage [%]: 9; Theoretical MW/pI: 59714/9.16; Spot ID: 2552; NCBI acc#: NP_004037.1; Mascot score: 182; N of identified peptides: 6; Sequence coverage [%]: 9; Theoretical MW/pI: 59714/ 9.16). Immunoblot with antibody to ATP synthase subunit a revealed a signal of the expected MW/pI corresponding to protein specifically recognized by patient's serum (Fig. 2C) , further confirming the results obtained by 2D immunoblot analysis with serum and mass spectrometry.
Localization of ATP Synthase Subunit a and Patient's IgG Staining in Skeletal Muscle Tissue
ATP synthase subunit a immunoreactivity was detected in all muscle fibers. The immunostaining had a granular distribution in the sarcoplasm. A patchy staining of the sarcolemma/subsarcolemmal area was also observed in several muscle fibers (Supplementary Data Fig. S1A, B) .
Patient's IgG stained no specific cellular structure in muscle tissue, a patchy reactivity was occasionally seen in sarcolemma/subsarcolemmal region of scattered muscle fibers (Supplementary Data Fig. S2A ). No reactivity was documented with serum IgG from controls (Supplementary Data  Fig. S2B ).
DISCUSSION
In the present study, we report a 27-year-old male patient complaining of acute proximal upper muscle weakness with pain of both acromioclavicular joints being unable to rise the arms up over 30
. Creatine kinase was normal but a myopathic pattern was recorded on electromyography. Histological analysis of deltoid muscle documented atrophy mainly of type 2B fibers and patchy loss of ATPase activity in a few 
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fibers. Pathological changes resembled those found in the myopathy with selective loss of thick filaments, a condition characterized by depletion of myosin filaments with disorganization of sarcomere structure that has been mainly reported in critically ill patients treated with high doses of corticosteroids or nondepolarizing neuromuscular blocking agents (5). However, our patient presented the peculiar ultrastructural abnormality of M-band dissolution and myofilaments misalignment in one or more contiguous sarcomeres with preserved Z band. The ultrastructural changes observed were similar to those described in 2 children and defined as "broad A band disease" because of the presence of misaligned sarcomere myosin causing broadening of the A-band (6). In addition, the M-line was primarily affected both in a congenital and early-onset severe titinopathy due to TTN deletions and in a conditional knockout mouse model for the titin M-band region. The acute onset of symptoms, the association with the rheumatic disease ankylosing spondylitis, the benign clinical course and the good response to TNF-a inhibitors suggested that an immune-mediated mechanism might be involved in the pathogenesis of the disease. Using a proteomic approach based on the 2D-PAGE separation of skeletal muscle proteins and subsequent immunoblot analysis with control and patient sera, we found that ATP synthase subunit a is specifically recognized by patient's serum IgG. The ATP synthase subunit a is a component of the F 1 core of the mitochondrial F 1 F 0 ATP synthase, the complex V of the electron transport chain responsible for ATP synthesis within mitochondria (7) . The ATP synthase is composed of a F 1 soluble catalytic core protruding in the mitochondrial matrix, which synthetizes the ATP from ADP and inorganic phosphate, and of a F 0 proton channel spanning the inner mitochondrial membrane that is responsible for power generation through the translocation of protons moving down their gradient (7) . Besides its canonical mitochondrial localization, the presence of several cell-surface ATP synthase subunits, referred to as ectopically expressed F 1 -ATP synthase (ecto-F 1 -ATP synthase), has been documented in different normal and tumoral mammalian cell lines including cardiomyoblasts, endothelial cells and hepatocytes (7, 8) .
However, the subunit composition and the structure of ecto-F 1 -ATP synthase and whether it is the same enzyme complex of the mitochondrial ATP synthase have not yet definitely determined (7) . Nevertheless, it is known that the cell-surface complex is implicated in different physiological roles, depending on the ligand and on the cell type (7). We documented a granular distribution of ATP synthase subunit a in the sarcoplasm of muscle fibers, a pattern compatible with its known mitochondrial localization (7) . Moreover, the patchy staining for ATP synthase subunit a in close proximity to the sarcolemma of several muscle fibers suggest that the protein might also be localized on the plasma membrane.
Autoantibodies to ATP synthases have been previously reported in other pathological conditions. Using an immunomics approach similar to the one adopted in the present study, it has been documented that subunit b of ATP synthase is recognized by serum of Alzheimer disease patients; the pathogenetic role of such antibodies was supported by studies on neuroblastoma cell lines and mice (9) . Serum autoantibodies to the subunit b have been also detected in patients with malignant mesothelioma and their high levels seem to be associated with the increased survival (10) . ATP synthase was identified as an antigenic target in patients affected by vasculitis, with higher frequency in primary vasculitis as compared with secondary vasculitis (11) . Finally, patients with idiopathic nephrotic syndrome had serum IgM class antibodies to ATP synthase b chain (12) .
An intriguing question is whether there is a link between ankylosing spondylitis and muscle disease in our patient. Ankylosing spondylitis, the most common form of spondyloarthritis, is an inflammatory chronic rheumatic disease that primarily affects axial skeleton with onset typically in the second or third decade of life (13) . The disease is more prevalent in men than in women and shows a strong genetic association with the MHC class I allele HLA-B*27 (13) . Emerging data suggest that immunologic mechanisms are involved in the pathogenesis of this disease and several antibodies have been identified in the blood of patients affected by the disease (13) . However, until now autoantibodies against ATP synthase or its subunits have not been detected in ankylosing spondylitis sera (13) . Muscle involvement has rarely been reported in this rheumatic disorder (14) . In literature, most of the patients with pathological abnormalities on muscle biopsy had neurogenic features including angulated atrophic fibers and/or target fibers or presented mild nonspecific myopathic changes, such as increased variation of fiber size and internal nuclei (14) . An inflammatory myopathy has been described as histological feature in a handful of single case reports for a total of 4 patients but a muscle disease with M-line loss was never documented in ankylosing spondylitis patients (14) .
In conclusion, this is the first case of acute muscle disorder with morphological alterations of the M-line and serum IgG autoantibodies to subunit a of ATP synthase. The occurrence of ATP synthase on cell surface makes its subunit a a potential antigenic target in our patient in which fiber necrosis and subsequent release of cellular contents were not observed. Several autoantibodies have been identified in various neuromuscular disorders including idiopathic inflammatory myopathies. Despite autoantibodies are useful diagnostic markers, their role in disease onset and progression is still unknown (15) . Similarly, the pathogenic role of antiATP synthase subunit a autoantibodies in this myopathy remains to be elucidated and further investigations are needed. The lack of data regarding the functions of cell-surface ATP synthase in skeletal muscle makes interpretation extremely difficult. An antibodymediated modulation in the expression levels of ecto-F 1 -ATPase with endocytosis and degradation of the immune complex leading to downregulation of functional enzyme could be involved. Alternatively, antibody binding could induce the blockage of ecto-F 1 -ATP synthase activity. The future understating of the functions of cell-surface ATP synthase in skeletal muscle would be helpful to shed light on the molecular events involved in the described acute M-line disease.
